Mineralys Therapeutics Inc
NASDAQ:MLYS 4:00:00 PM EDT
Mineralys Therapeutics Inc Stock, NASDAQ:MLYS
150 North Radnor Chester Road, Suite F200, Radnor, Pennsylvania 19087
United States of America
Phone: +1.888.378.6240
Number of Employees: 28
Description
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.